1. Home
  2. LUNA vs CGTX Comparison

LUNA vs CGTX Comparison

Compare LUNA & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNA
  • CGTX
  • Stock Information
  • Founded
  • LUNA 1990
  • CGTX 2007
  • Country
  • LUNA United States
  • CGTX United States
  • Employees
  • LUNA N/A
  • CGTX N/A
  • Industry
  • LUNA Biotechnology: Commercial Physical & Biological Resarch
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LUNA Health Care
  • CGTX Health Care
  • Exchange
  • LUNA Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • LUNA 67.3M
  • CGTX 79.3M
  • IPO Year
  • LUNA 2006
  • CGTX 2021
  • Fundamental
  • Price
  • LUNA $1.63
  • CGTX $0.46
  • Analyst Decision
  • LUNA Strong Buy
  • CGTX Buy
  • Analyst Count
  • LUNA 1
  • CGTX 6
  • Target Price
  • LUNA $8.00
  • CGTX $8.00
  • AVG Volume (30 Days)
  • LUNA 159.9K
  • CGTX 633.0K
  • Earning Date
  • LUNA 11-22-2024
  • CGTX 11-13-2024
  • Dividend Yield
  • LUNA N/A
  • CGTX N/A
  • EPS Growth
  • LUNA N/A
  • CGTX N/A
  • EPS
  • LUNA N/A
  • CGTX N/A
  • Revenue
  • LUNA $116,614,000.00
  • CGTX N/A
  • Revenue This Year
  • LUNA $13.35
  • CGTX N/A
  • Revenue Next Year
  • LUNA $11.96
  • CGTX N/A
  • P/E Ratio
  • LUNA N/A
  • CGTX N/A
  • Revenue Growth
  • LUNA 14.31
  • CGTX N/A
  • 52 Week Low
  • LUNA $1.43
  • CGTX $0.34
  • 52 Week High
  • LUNA $7.92
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • LUNA 44.55
  • CGTX 43.54
  • Support Level
  • LUNA $1.55
  • CGTX $0.48
  • Resistance Level
  • LUNA $1.80
  • CGTX $0.62
  • Average True Range (ATR)
  • LUNA 0.14
  • CGTX 0.05
  • MACD
  • LUNA 0.02
  • CGTX 0.00
  • Stochastic Oscillator
  • LUNA 50.00
  • CGTX 11.92

About LUNA Luna Innovations Incorporated

Luna Innovations Inc is engaged in optical technology, providing high-performance fiber optic test, measurement, and control products for the telecommunications, and photonics industries, and distributed fiber optic sensing solutions that measure and monitor materials and structures for applications in aerospace, automotive, oil, and gas, security, and infrastructure. Its Lightwave segment develops, manufactures, and markets optical measurements technologies like Sensing including short, medium, and long-range distributed fiber optic sensing solutions and Terahertz measurement products, and Communications test and photonic control including test equipment for communications devices and networks and specialty laser and photonic components. It derives a majority of its revenue from the U.S.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: